AzTrials
AzTrials

MalnutritionCHAINNCT03208725

Childhood Acute Illness and Nutrition Network

An observational study of Malnutrition and Pneumonia, run by University of Oxford at 8 sites in 5 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The CHAIN Network aims to identify modifiable biomedical and social factors driving the greatly increased risk of mortality among young undernourished children admitted to hospital with acute illness, as inpatients and after discharge. Read more about this study

Who is it for?
Ages 2 to 23 months
Conditions the study is for
Malnutrition, Pneumonia, Diarrhea
How many people
4,335 participants
Where
8 sitesin 5 countries
Study dates
30 Nov 2016to 31 Oct 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 23 months
  • All sexes
  • No healthy volunteers
  • Child

Study population: Hospital and post-discharge cohort: Children being admitted to hospital. Community reference participants: Children living in the same communities as those recruited into the hospitalized cohort.

Who may be able to join

  • Children 2 months-23 months.
  • Admitted to hospital.
  • Planning to remain within the hospital catchment area and willing to come for specified visits during the 6 month follow up period.
  • Parent or guardian consents on child's behalf.
  • Aged 2 to 23 months
  • Living in the same community as the acutely ill children recruited.
Show all 11Show fewer
  • Not having an acute illness requiring hospital admission
  • Absence of known, but untreated HIV or TB
  • Not admitted to hospital within the last 14 days
  • Not previously included in the study
  • Parent or guardian consents on child's behalf.

Who cannot join

  • Requiring immediate resuscitation at admission to hospital*
  • Unable to tolerate oral feeds while in his/her usual state of health
  • Underlying terminal illness that in the opinion of the treating physician is likely to lead to death within 6 months (e.g., cancer, congenital heart disease)
  • Diagnosed with a condition that in the opinion of the treating physician is likely to require surgery within 6 months
  • Diagnosed chromosomal abnormality (syndromically or genetically diagnosed abnormality)
  • Primary reason for admission is poisoning, trauma or a surgical condition
Show all 9Show fewer
  • Previously enrolled in this study
  • Sibling currently or previously enrolled in this study
  • ( children requiring resuscitation will be defined as those with on-going cardiac or pulmonary arrest or judged to be peri-arrest by the attending physician)

Trial locations and contacts

8 sites in 5 countries.

8 sites in 5 countries

Kenya3 sites
  • Kilifi County Hospital

    Kilifi

  • Migori County Hospital

    Migori

  • Mbagathi District Hospital

    Nairobi

Other trials in Kenya

Bangladesh2 sites
  • Matlab Hospital

    Dhaka, Chittagong

  • ICDDR,B Dhaka Hospital

    Dhaka

Other trials in Bangladesh

Malawi1 site
  • Queen Elizabeth Central Hospital

    Blantyre

Other trials in Malawi

Pakistan1 site
  • Civil Hospital Karachi

    Karachi

Other trials in Pakistan

Uganda1 site
  • Mulago Hospital

    Kampala

Other trials in Uganda

About this study

Official title: Building the Evidence Base for Appropriate Care of the Sick, Undernourished Child in Limited Resource Settings

The CHAIN Network aims to identify modifiable biomedical and social factors driving the greatly increased risk of mortality among young undernourished children admitted to hospital with acute illness, as inpatients and after discharge. The study will inform priorities, risks and targeting for multi-faceted interventional trials.

CHAIN is a multi-centre cohort study with a nested case control analysis of stored biological samples. Study sites are located in Africa and South Asia. Children will be recruited at admission to hospital, stratified by nutritional status. Exposures will be assessed at admission, during hospitalisation, at discharge, and at two time points after discharge. The main outcomes of interest are mortality, re-admission to hospital and failure of nutritional recovery up to 180 days after discharge. To determine community health norms, an additional sample of children living in the same communities will be enrolled and assessed at one time point only.

Read the detailed description

Despite an overall reduction of child mortality in LMICs, acutely-ill undernourished children continue to have a greatly elevated risk of death, both during hospitalisation and following discharge. However, we currently lack robust evidence for their management. Factors underlying the risks of mortality may relate to the acute illness itself, to children's longer term health trajectories, or to the home nutritional and care environment. The ultimate goal of the CHAIN Network is to identify and prioritize actionable intervention targets to reduce mortality among acutely ill undernourished children.

CHAIN's initial aim is to better understand the characteristics that determine increased risk of mortality in this vulnerable population, whether biological (related to infection, immunity and metabolism), nutritional (intake and anthropometry), health system factors (affecting management and discharge) or behavioural (community/caregiver interactions). CHAIN brings clinicians and scientists together from a variety of high-burden settings in Africa and South Asia. CHAIN will establish prospective cohorts of acutely ill young children across different geographies with differing population, social and environmental characteristics (stunted vs. wasting, rural vs. urban and presence of risk factors such as malaria and HIV).

Eight sites will be involved, including three hospitals in Kenya (Kilifi County, Migori County and Mbagathi District), two in Bangladesh (Matlab and the icddr,b Dhaka), and one in each of Uganda (Mulago), Malawi (Queen Elizabeth Community Hospital), Pakistan (Civil Hospital Karachi) and in West Africa (TBA). Site will enroll children at admission to hospital, and assess their clinical, social and economic status at admission, during hospitalisation, at discharge and during follow up for 180 days after discharge. The sites will also enrol children from the community to determine community norms (where ill and undernourished children would be expected to typically recover to). Protocols and procedures will be carefully harmonised across sites.

Children aged 2 months to 2 years admitted to hospital will be considered for inclusion and enrolment stratified by nutritional status. Following informed consent, baseline data of prognostic importance, including demographic and social information, a detailed clinical examination, anthropometry and measurement of vital signs, including pulse oximetry, will be collected using a standard proforma. A research blood sample will be collected together with the routine clinical blood draw to minimize the patient's discomfort. Rectal swabs and faecal sample will also be obtained from all children.

During admission, care will be provided according to WHO and national guidelines. Children will be reviewed daily and clinical features, progress and treatment received recorded on a structured case report form. In the event of death in hospital, a standard audit questionnaire will be completed. During admission, primary caregivers, usually the mother, will be interviewed screened for mental health problems. At discharge, anthropometry, a clinical assessment and blood, rectal swab and whole stool collected. Families will be linked with chronic care services where needed.

A home visit will be conducted for all participants, the GPS location recorded. Information homestead infrastructure, water and sanitation, population, livelihood, child care and socioeconomic characteristics. Children will be followed up at 45, 90 and 180 days after discharge. A health questionnaire will document health and social events, and dietary intake. Anthropometry, and faecal and blood samples collected.

Caregivers will be asked to attend the study hospital should the caregiver believes they may require hospitalisation. Study participants who are re-admitted to hospital will undergo standardised clinical assessment including history, examination and sample collection. In the event of death occurring outside the study hospital, a standard verbal autopsy (VA) will be completed by trained staff within 28 days of becoming aware of a death. VAs along with all available information will be used to ascribe causes of death.

Community participants will be invited to the study clinic for assessment. Following informed consent, they will have a clinical examination, anthropometry, blood and stool samples as children who are admitted. Children requiring non-urgent medical care will be eligible for inclusion as community participants but will be given basic treatment in the study clinic and/or referred to appropriate treatment centres. Study staff will refer community participants with incomplete vaccination or requiring care for chronic conditions as needed.

Several domains of exposure will be assessed: demographic, nutrition and metabolism; acute and chronic conditions; community-acquired and nosocomial infections (including antimicrobial resistance); gut function \& dysbiosis; inflammation; responses to treatment; and the home care environment.

Successful design of an intervention package to address post-discharge child mortality will require attention social and economic agency and vulnerability, access and interactions with health services, and ethical considerations. A qualitative sub-study will examine these factors in context in rural and urban sites in Kenya and Bangladesh to identify critical social limitations and potential approaches to intervention. These data will inform the network's development, piloting, and implementation of interventions.

Additional sub-studies at a subset of sites will also examine in more detail the diagnosis and role of TB; and changes in functional immune responses; body composition and neurodevelopment during follow up.

Keywords
Malnutrition, Hospitalization, Acute Illness, Pediatric, Post-discharge mortality, Mortality, Cohort, Nested case control, Antimicrobial resistance, Antibiotic, Feeding, Undernutrition
Medical subject headings
Malnutrition, Pneumonia, Diarrhea, Sepsis, Bacteremia, Acquired Immunodeficiency Syndrome, Intestinal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT03208725
Study groupRoleWhat they receive
Hospitalized children with severe wasting or kwashiorkor (SWK)Children recruited at admission to hospital and followed up for 180 days post-discharge.
Community reference participants (CP)Children recruited from the community who are seen a single appointment in the community.
Hospitalized children with moderate wasting (MW)Children recruited at admission to hospital and followed up for 180 days post-discharge.
Hospitalized children without wasting (NW)Children recruited at admission to hospital and followed up for 180 days post-discharge.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mortality

    Assessed using clinical and civil records and verbal autopsy

    Measured: Up to 30 days after admission to hospital

  2. Mortality

    Assessed using clinical and civil records and verbal autopsy

    Measured: Up to 180 days after discharge from hospital

Secondary outcomes (4)
  1. Rehospitalization

    Number of participants, assessed from direct observation or clinical records

    Measured: Up to 180 days after discharge from hospital

  2. Change in weight-for-height z-score

    Post-discharge growth

    Measured: Up to 180 days after discharge from hospital

  3. Change in length-for-age z-score

    Post-discharge growth

    Measured: Up to 180 days after discharge from hospital

  4. Change in mid-upper arm circumference

    Post-discharge growth

    Measured: Up to 180 days after discharge from hospital

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jul 2017
  2. Study start30 Nov 2016
  3. Primary completion31 Jan 2020
  4. Study completion31 Oct 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
4,335 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03208725
Sponsor's protocol ID
OPP1131320
Acronym
CHAIN
Status last verified
May 2020
First submitted
8 Mar 2017
Last updated
20 May 2020
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Njunge JM, Tickell K, Diallo AH, Sayeem Bin Shahid ASM, Gazi MA, Saleem A, Kazi Z, Ali S, Tigoi C, Mupere E, Lancioni CL, Yoshioka E, Chisti MJ, Mburu M, Ngari M, Ngao N, Gichuki B, Omer E, Gumbi W, Singa B, Bandsma R, Ahmed T, Voskuijl W, Williams TN, Macharia A, Makale J, Mitchel A, Williams J, Gogain J, Janjic N, Mandal R, Wishart DS, Wu H, Xia L, Routledge M, Gong YY, Espinosa C, Aghaeepour N, Liu J, Houpt E, Lawley TD, Browne H, Shao Y, Rwigi D, Kariuki K, Kaburu T, Uhlig HH, Gartner L, Jones K, Koulman A, Walson J, Berkley J. The Childhood Acute Illness and Nutrition (CHAIN) network nested case-cohort study protocol: a multi-omics approach to understanding mortality among children in sub-Saharan Africa and South Asia. Gates Open Res. 2022 Nov 3;6:77. doi: 10.12688/gatesopenres.13635.2. eCollection 2022.

    PubMed 36415883
  • Tickell KD, Denno DM, Saleem A, Ali A, Kazi Z, Singa BO, Otieno C, Mutinda C, Ochuodho V, Richardson BA, Asbjornsdottir KH, Hawes SE, Berkley JA, Walson JL. Enteric Permeability, Systemic Inflammation, and Post-Discharge Growth Among a Cohort of Hospitalized Children in Kenya and Pakistan. J Pediatr Gastroenterol Nutr. 2022 Dec 1;75(6):768-774. doi: 10.1097/MPG.0000000000003619. Epub 2022 Sep 20.

    PubMed 36123771
  • Childhood Acute Illness and Nutrition Network. Childhood Acute Illness and Nutrition (CHAIN) Network: a protocol for a multi-site prospective cohort study to identify modifiable risk factors for mortality among acutely ill children in Africa and Asia. BMJ Open. 2019 May 5;9(5):e028454. doi: 10.1136/bmjopen-2018-028454.

    PubMed 31061058

Questions about this trial

What is this clinical trial studying?

An observational study of Malnutrition and Pneumonia, run by University of Oxford at 8 sites in 5 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in Kenya, Bangladesh, Malawi, Pakistan, Uganda. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mortality (time frame: Up to 30 days after admission to hospital). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03208725, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in